Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 25, 2024Journal of Diabetes & Metabolic DisordersOpen Access

Narrative review of data supporting alternate first-line therapies over metformin in type 2 diabetes

View Full Paper
Ask AI
Bookmark
Share

Authors

JAJohn AndraosCedars-Sinai Medical CenterSSShawn SmithWestern University of Health SciencesATAmanda TranHoag Memorial Hospital Presbyterian

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Andraos et al. (2024) studied this question.

synapsesocial.com/papers/68e72652b6db6435876a0660https://doi.org/10.1007/s40200-024-01406-6
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes2017 · 7,923 citations
  2. 2Liraglutide and Metformin alone or combined therapy for type 2 diabetes patients complicated with coronary artery disease2017 · 35 citations
  3. 3Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy2019 · 6,247 citations
  4. 4Efficacy of Metformin in Patients with Non-Insulin-Dependent Diabetes Mellitus1995 · 1,376 citations
  5. 5Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis2019 · 346 citations